Cigna Group (CI) shares fell 2.91% to close near $306.70, failing to sustain momentum above the $315.72 intraday high and trading near its 52-week peak of $316.27. The decline was driven primarily by technical overextension rather than fundamental deterioration, as the stock's Relative Strength Index (RSI) spiked to an extreme 88.4, signaling an overbought condition that prompted profit-taking among algorithmic and institutional traders. Despite the short-term pullback, analysts maintain a 'Moderate Buy' rating with a price target of $338.24, implying approximately 10.1% upside from current levels. The stock trades at a dynamic P/E ratio of roughly 12.23 and offers a healthy dividend yield of 2.05%, suggesting the long-term bullish trend remains intact despite the technical reset. The selling pressure on Cigna was not isolated but mirrored broader weakness in the Managed Health Care sector, with competitor UnitedHealth Group (UNH) also dropping 1.69%. This correlation indicates that the move is partly driven by sector-wide rotation or macroeconomic concerns affecting large-cap healthcare insurers rather than company-specific news. Technically, Cigna is trading well above its key moving averages, including the 200-day average at $280.94 and the 100-day average at $283.43, which serve as strong support levels. The stock recently pierced its upper Bollinger Band, a common trigger for mean reversion, making a pullback toward the $285-$290 range technically probable to cool the RSI before potentially resuming its upward trajectory.